Novel Hybrids of Podophyllotoxin and Coumarin Inhibit the Growth and Migration of Human Oral Squamous Carcinoma Cells

被引:11
作者
Bai, Guohui [1 ,2 ]
Zhao, Dan [1 ,2 ]
Ran, Xin [1 ,2 ]
Zhang, Lei [3 ,4 ]
Zhao, Degang [1 ,2 ,5 ]
机构
[1] Guizhou Univ, Inst Agrobioengn, Minist Educ, Key Lab Plant Resources Conservat & Germplasm Inn, Guiyang, Peoples R China
[2] Guizhou Univ, Coll Life Sci, Guiyang, Peoples R China
[3] Zunyi Med Univ, Key Lab Biocatalysis & Chiral Drug Synth Guizhou, Zunyi, Guizhou, Peoples R China
[4] Zunyi Med Univ, Sch Pharm, Zunyi, Guizhou, Peoples R China
[5] Guizhou Acad Agr Sci, Inst Guizhou Distinct Plant Resources Conservat, Guiyang, Peoples R China
基金
中国国家自然科学基金;
关键词
podophyllotoxin; coumarin; hybrid strategy; human oral squamous carcinoma cells; anticancer; molecular mechanism; DERIVATIVES; CANCER; PROGRESSION; AUTOPHAGY; ANALOGS;
D O I
10.3389/fchem.2020.626075
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Oral squamous cell carcinoma is the most common malignancy of oral tumor. In this study, two novel hybrids of podophyllotoxin and coumarin were designed using molecular hybridization strategy and synthesized. Pharmacological evaluation showed that the potent compound 12b inhibited the proliferation of three human oral squamous carcinoma cell lines with nanomolar IC50 values, as well as displayed less toxicity on normal cells. Mechanistic studies indicated that 12b triggered HSC-2 cell apoptosis, induced cell cycle arrest, and inhibited cell migration. Moreover, 12b could disturb the microtubule network via binding into the tubulin. It was noteworthy that induction of autophagy by 12b was associated with the upregulation of Beclin1, as well as LC3-II. Furthermore, 12b significantly stimulated the AMPK pathway and restrained the AKT/mTOR pathway in HSC-2 cells. These results indicated that compound 12b was a promising candidate for further investigation.
引用
收藏
页数:13
相关论文
共 32 条
[1]   Podophyllotoxin derivatives: Drug discovery and development [J].
Bohlin, L ;
Rosen, B .
DRUG DISCOVERY TODAY, 1996, 1 (08) :343-351
[2]  
Fen D., 2014, NAT PROD RES DEV, V26, P679, DOI [10.16333/j.1001-6880.2014.05.010, DOI 10.16333/J.1001-6880.2014.05.010]
[3]   Natural and synthetic coumarin derivatives with anti-inflammatory/antioxidant activities [J].
Fylaktakidou, KC ;
Hadjipavlou-Litina, DJ ;
Litinas, KE ;
Nicolaides, DN .
CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (30) :3813-3833
[4]   The Role of p53 Protein and MMP-2 Tumor/Stromal Cells Expression on Progressive Growth of Ovarian Neoplasms [J].
Grelewski, Piotr Grzegorz ;
Bar, Julia Krystyna .
CANCER INVESTIGATION, 2013, 31 (07) :472-479
[5]   Dehydrozingerone Inspired Styryl Hydrazine Thiazole Hybrids as Promising Class of Antimycobacterial Agents [J].
Hampannavar, Girish A. ;
Karpoormath, Rajshekhar ;
Palkar, Mahesh B. ;
Shaikh, Mahamadhanif S. ;
Chandrasekaran, Balakumar .
ACS MEDICINAL CHEMISTRY LETTERS, 2016, 7 (07) :686-691
[6]   Novel conjugates of podophyllotoxin and coumarin: Synthesis, cytotoxicities, cell cycle arrest, binding CT DNA and inhibition of Topo IIβ [J].
Hao, Shu-Yi ;
Feng, Shi-Liang ;
Wang, Xing-Rong ;
Wang, Zhichao ;
Chen, Shi-Wu ;
Hui, Lin .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (16) :2129-2135
[7]   Cyclin-dependent kinases and cell-cycle transitions: does one fit all? [J].
Hochegger, Helfrid ;
Takeda, Shunichi ;
Hunt, Tim .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2008, 9 (11) :910-U26
[8]   Beyond a tumor suppressor: Soluble E-cadherin promotes the progression of cancer [J].
Hu, Qi-Ping ;
Kuang, Jing-Ya ;
Yang, Qing-Kai ;
Bian, Xiu-Wu ;
Yu, Shi-Cang .
INTERNATIONAL JOURNAL OF CANCER, 2016, 138 (12) :2804-2812
[9]   Combination of 7-hydroxycoumarin in a platinum(IV) complex derived from cisplatin enhanced cytotoxicity with multiple mechanisms of action [J].
Hua, Wuyang ;
Zhao, Jian ;
Hu, Weiwei ;
Gou, Shaohua .
JOURNAL OF INORGANIC BIOCHEMISTRY, 2018, 186 :17-23
[10]   4-Methylumbelliferones Analogues as Anticancer Agents: Synthesis and in Cell Pharmacological Studies [J].
Huang, Ri-Zhen ;
Hua, Shi-Xian ;
Wang, Cai-Yi ;
Pan, Ying-Ming ;
Qin, Jian-Mei ;
Ding, Zhan-Yu ;
Zhang, Ye ;
Wang, Heng-Shan .
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2017, 17 (04) :576-589